Ortivus’ Year-end Report, January – December 2020

Ortivus – An eHealth company on the front line

Highlights Oct – Dec 2020

  • Ortivus signs a contract with Region Jönköping for the delivery of MobiMed monitoring, hardware and software, to all of the regions emergency vehicles. The order value is approximately 9.0 MSEK
  • Ortivus communicates that production, reparations and warehouse management of MobiMed Monitoring, will be moved to Ortivus' own premises in Danderyd and taken over by Ortivus' own personnel. Mentioned functions are today handled by Inission in Västerås.
  • Ortivus signs an exclusive distribution agreement with OsatuS. Coop / Bexencardio. The agreement gives Ortivus the possibility to offer Bexencardios AEDs. The agreement is valid for the Nordic countries, UK and Ireland.

Oct – Dec 2020

  • Net sales amounted to 21.9 (17.1) MSEK, which is an increase in sales of 27.8%
  • Operating profit cleared for comparative distortion items amounted to 2.2 (-1.7) MSEK. Operating profit, including comparative distortion items, amounted to 2.2 (-1.7) MSEK
  • EBITDA cleared for comparative distortion items, amounted to 2.5 (0.2) MSEK. EBITDA including comparative distortion items, amounted to 2.5 (0.2) MSEK
  • Profit after tax was 2.2 (-1.7) MSEK
  • Earnings per share after tax amounted to 0.05 (-0.04) SEK

Jan – Dec 2020

  • Net sales amounted to 107.6 (50.8) MSEK, which is an increase in sales of 111.6%
  • Operating profit cleared for comparative distortion items, amounted to 11.4 (-10.2) MSEK. Operating profit including comparative distortion items, amounted to 11.4 (-15.5) MSEK
  • EBITDA cleared for comparative distortion items, amounted to 13.9 (-8.5) MSEK. EBITDA including comparative distortion items, amounted to 13.9 (-8.5) MSEK
  • Profit after tax was 11.3 (16.0) MSEK
  • Earnings per share after tax amounted to 0.26 (-0.41) SEK
Amount in KSEK Okt – Dec 2020 Okt – Dec 2019 Jan – Dec 2020 Jan – Dec 2019
Net sales 21 863 17 101 107 582 50 848
Gross margin, % 49.0% 49.6% 36.2% 41.3%
Operating profit,
excl. comparative distortion items		 2 167 -1 731 11 392 -10 197
Operating margin, %
excl. comparative distortion items		 9.9% -10.1% 10.6% -20.1%
EBITDA,
excl. comparative distortion items		 2 459 200 13 896 -3 271

Contacts

For further information, please contact

Reidar Gårdebäck, CEO

Telefon +46 8 446 45 00

About Ortivus

Ortivus develops and commercialises MobiMed, medical technology solutions for a safer and more efficient
healthcare. The company was founded in 1985 and is today a leading provider of mobile digital
solutions for prehospital care, worldwide. Ortivus' products are based on in-depth expertise
in cardiology as well as decades of development together with users and customers. The company's headquarters are located in Danderyd, Stockholm and the company has, since 1998, a wholly-owned subsidiary based in the United Kingdom.

MobiMed is a modular platform that currently is used by over 12 000 paramedics in over 2 700 emergecy vechicles. The platform consists of a monitor that in real-time measures, monitors and shares patients'
vital parameters, such as, ECG, blood pressure and blood oxygenation. The system also consists
of an electronic patient record for decision support, collection of patient data and clinical documentation.
MobiMed has a total weight of 2.5kg and is created to function in a demanding environment and out in
the field. The two-way communication supports telemedicine consulting with clinical experts while patient data is seamlessly integrated into the medical records at the hospitals and primary care centers. MobiMed saves time and helps healthcare professionals make the right decisions in critical situations. MobiMed also contributes to improved quality of care and saved resources.

Ortivus Class A and Class B shares are listed on the NASDAQ Stockholm Small Cap list.

Read more about Ortivus at www.ortivus.com

This information is information that Ortivus is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 2021-02-16 08:30 CET.

Attachments

Ortivus Year End Report January December 2020

This entry was posted in . Bookmark the permalink.